Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-268.80 · Revenue $100000.00 · 1 analysts
Est. EPS $880.80 · Revenue $80.58M · 1 analysts
Est. EPS $1317.60 · Revenue $118.08M · 1 analysts
EPS $-0.84 · Revenue $0.00
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $747000 | +1637.2% | -56.8% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-3.0M | +73.3% | -105.6% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +18.5% | -81.5% | +27.9% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -1128.1% | +96.0% | -293.4% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -401.3% | +98.5% | -376.0% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-4.8M | +40.3% | -26.2% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -638.6% | +96.6% | -192.1% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 0.0% | — | — |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 4.70x | +701.3% | +22.1% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $8.2M | +99.9% | +3.8% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -6.45 vs -283.20 | +97.7% | -0.08 vs -72.00 | +99.9% |
| Revenue Surprise | $747000 vs $100000 | +647.0% | $336000 vs $25000 | +1244.0% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Kiu Cu Seng | director, officer: Chief Financial Officer | Common Stock | A | 200,000 | $1.40 |
| Nov 12, 2025 | Doris Wong Sing Ee | director, 10 percent owner, officer: Chief Executive Officer | Common Stock | A | 300,178 | $1.40 |
| Nov 5, 2025 | Yap Kim Choy | 10 percent owner | Common Stock | A | 467,535 | — |
| Nov 5, 2025 | Yap Kim Choy | 10 percent owner | Series A Common Stock Warrants | D | 218,000 | $7.65 |
| Nov 5, 2025 | Yap Kim Choy | 10 percent owner | Series B Common Stock Warrants | D | 218,000 | $9.00 |
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Sing Ee Wong | Chairman, Chief Executive Officer & President | USD 50,536 | — | 1981 | Active |
Cu Seng Kiu | Executive Director, Chief Financial Officer & Secretary | USD 5,054 | Male | 1990 | Active |
Grace Kim | Investor Relations Executive | — | — | — | Active |
Gill Christie | Director of Human Resources | — | Female | 1957 | Active |
KUALA LUMPUR, MALAYSIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced second quarter financial results and provided a business update.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) and Peak Pharmaceuticals (OTCMKTS:PKPH - Get Free Report) are both small-cap manufacturing companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Profitability This table compares Cyclacel Pharmaceuticals and
Bio Green Med Solution, Inc. (NASDAQ:BGMS) shares are trading higher Friday after the company announced it entered into a Business Combination Agreement with Future NRG.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Bio Green Med Solution, Inc. (NASDAQ: BGMS) and Future NRG Sdn. Bhd. Halper Sadeh encourages BGMS shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether BGMS and its board of directors violated the federal securiti.
